Tetra Radar · FDA Approvals · Decision date
Telix Pharmaceuticals Ltd: FDA decision date
Telix Pharmaceuticals Ltd (TLX) · 6 March 2026
In August 2025, Lantheus announced that its NDA for a new formulation of its fluorine-18 based PSMA . imaging agent, had been accepted by the FDA with a PDUFA goal date of March 6, 2026.
Source: 20-F of 20 February 2026
The date has passed; Tetra Radar has not recorded an approval.
Telix Pharmaceuticals Ltd on Tetra Radar
A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.